HSA — authorised 8 November 2001
- Marketing authorisation holder: ENDO PHARMS
- Status: likely_approved
HSA authorised Frova on 8 November 2001
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Yes. HSA authorised it on 8 November 2001.
ENDO PHARMS holds the Singaporean marketing authorisation.